Discover
AEON
AEON Biopharma, Inc.
0.27
1 x 0.25
1 x 0.32
bid
ask
-
0.00
1.59%
1 @ 04:00 PM
0.27 +0.00 (0.00%)
| Ytd | -75.18% | |
| 1y | -58.45% |
0.27
day range
0.28
0.22
52 week range
1.45
| Open | 0.28 | Prev Close | 0.28 | Low | 0.27 | High | 0.28 | Mkt Cap | 12.06M |
| Vol | 0.00 | Avg Vol | 1.32M | EPS | -5.15 | P/E | -0.05 | Forward P/E | -0.84 |
| Beta | 0.40 | Short Ratio | 1.60 | Inst. Own | 33.14% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 0.52 | 200-d Avg | 0.87 | 1yr Est | 5.00 |
| Income Statement | |||
| Operating Expenses | 5.93M | ||
| Research and Development Expense | 2.03M | ||
| Selling, General and Administrative Expense | 3.90M | ||
| Operating Income | -5.93M | ||
| Net Income | -11.79M | ||
| Net Income Common Stock | -11.79M | ||
| Net Income Common Stock (USD) | -11.79M | ||
| Consolidated Income | -11.79M | ||
| Earnings per Basic Share | -0.29 | ||
| Earnings per Basic Share (USD) | -0.29 | ||
| Earnings per Diluted Share | -0.29 | ||
| Earning Before Interest & Taxes (EBIT) | -11.79M | ||
| Earning Before Interest & Taxes (USD) | -11.79M | ||
| Weighted Average Shares | 40.61M | ||
| Weighted Average Shares Diluted | 40.61M | ||
| Balance Sheet | |||
| Cash and Equivalents | 6.24M | ||
| Cash and Equivalents (USD) | 6.24M | ||
| Current Assets | 6.63M | ||
| Property, Plant & Equipment Net | 1.13M | ||
| Total Assets | 8.63M | ||
| Total Debt | 2.37M | ||
| Current Liabilities | 6.67M | ||
| Debt Non-Current | 2.37M | ||
| Total Liabilities | 25.38M | ||
| Accumulated Retained Earnings (Deficit) | -482.61M | ||
| Shareholders Equity | -16.75M | ||
| Shareholders Equity (USD) | -16.75M | ||
| Assets Non-Current | 2.01M | ||
| Total Debt (USD) | 2.37M | ||
| Liabilities Non-Current | 18.71M | ||
| Trade and Non-Trade Payables | 1.48M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 19.00K | ||
| Net Cash Flow from Financing | 5.87M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 3.24M | ||
| Issuance (Purchase) of Equity Shares | 5.87M | ||
| Net Cash Flow from Operations | -2.64M | ||
| Share Based Compensation | 1.93M | ||